Phan, B. A. P., Muñoz, L., Shadzi, P., Isquith, D., Triller, M., Brown, B. G., & Zhao, X. (2012). Effects of Niacin on Glucose Levels, Coronary Stenosis Progression, and Clinical Events in Subjects With Normal Baseline Glucose Levels (<100 mg/dl): A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI During Lipid-Lowering (CPC) Study.

Phan, Binh An P., Luis Muñoz, Pey Shadzi, Daniel Isquith, Michael Triller, B. Greg Brown, and Xue-Qiao Zhao. Effects of Niacin On Glucose Levels, Coronary Stenosis Progression, and Clinical Events in Subjects With Normal Baseline Glucose Levels (<100 Mg/dl): A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition By MRI During Lipid-Lowering (CPC) Study. 2012.

Phan, Binh An P., et al. Effects of Niacin On Glucose Levels, Coronary Stenosis Progression, and Clinical Events in Subjects With Normal Baseline Glucose Levels (<100 Mg/dl): A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition By MRI During Lipid-Lowering (CPC) Study. 2012.